Search

Your search keyword '"Mazia, Claudio"' showing total 37 results

Search Constraints

Start Over You searched for: Author "Mazia, Claudio" Remove constraint Author: "Mazia, Claudio"
37 results on '"Mazia, Claudio"'

Search Results

1. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

2. Randomized Trial of Thymectomy in Myasthenia Gravis

3. Choline Acetyltransferase Mutations Causing Congenital Myasthenic Syndrome: Molecular Findings and Genotype–Phenotype Correlations

4. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

5. Long-term effect of thymectomy plus prednisone versus prednisone alone in patients with non-thymomatous myasthenia gravis: 2-year extension of the MGTX randomised trial

6. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

7. Estudio epidemiológico multicéntrico sobre esclerosis lateral amiotrófica en la Ciudad de Buenos Aires

8. Consenso argentino para el diagnóstico, seguimiento y tratamiento de la enfermedad de Pompe

9. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab:subgroup analysis of REGAIN and its extension study

11. ‘Minimal symptom expression’ in patients with acetylcholine receptor antibody-positive refractory generalized myasthenia gravis treated with eculizumab

12. Eculizumab in refractory generalized myasthenia gravis previously treated with rituximab: subgroup analysis of REGAIN and its extension study.

13. Long-term safety and efficacy of eculizumab in generalized myasthenia gravis

14. Response to eculizumab in patients with myasthenia gravis recently treated with chronic IVIg: a subgroup analysis of REGAIN and its open-label extension study

15. Consenso argentino sobre enfermedad de Pompe de inicio tardío

16. Long-term efficacy and safety of eculizumab in Japanese patients with generalized myasthenia gravis: A subgroup analysis of the REGAIN open-label extension study

17. Eculizumab improves fatigue in refractory generalized myasthenia gravis

18. Consistent improvement with eculizumab across muscle groups in myasthenia gravis.

20. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

21. Safety and efficacy of eculizumab in anti-acetylcholine receptor antibody-positive refractory generalised myasthenia gravis (REGAIN): a phase 3, randomised, double-blind, placebo-controlled, multicentre study

24. Adverse Outcome of Early Recurrent Ischemic Stroke Secondary to Atrial Fibrillation after Repeated Systemic Thrombolysis

25. Screening of the intronic expansion in the C9 orf72 gene and the ATXN2 mutation in Argentine patients diagnosed with Amyotrophic Lateral Sclerosis (P2.056)

27. Multicenter Epidemiological Study of Amyotrophic Lateral Sclerosis in the City of Buenos Aires (P2.057)

28. Inmunoglobulina endovenosa en enfermedades neuromusculares. Guía para su utilización

33. TERAPEUTICAS INTERVENCIONISTAS PARA EL ACCIDENTE CEREBROVASCULAR ISQUEMICO.

34. Adverse Outcome of Early Recurrent Ischemic Stroke Secondary to Atrial Fibrillation after Repeated Systemic Thrombolysis

36. [Argentine consensus on late-onset Pompe's disease].

37. [Update on interventional treatment of acute ischemic stroke].

Catalog

Books, media, physical & digital resources